Can Ozempic Help With Alcohol Addiction?

Drugs designed to aid weight loss and treat type 2 diabetes might also be game-changers for people battling alcohol and opioid addiction, according to new research.

The injections, including well-known brands like Ozempic and Mounjaro, were linked to significantly lower rates of alcohol intoxication and opioid overdoses, offering hope for new addiction treatments.

A Surprising Connection Between Appetite and Addiction

The study, published in the journal Addiction, explored the effects of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as Ozempic, and glucose-dependent insulinotropic polypeptide (GIP) drugs, like Mounjaro. While these medications are commonly prescribed to regulate appetite and blood sugar levels, researchers found they might also influence parts of the brain tied to addictive behaviors.

DISCOVER: Meet Livia, a gadget promising to ‘switch off’ period pain

MORE: Electric Headset for Depression Gains NHS Approval

“These drugs may help curb addictions by targeting the brain’s reward pathways,” experts suggest, hinting at their potential beyond weight loss.

Significant Reductions in Alcohol and Opioid Use

The study analysed data from over 817,000 individuals with a history of alcohol use disorder. Among them, 5,621 were prescribed GLP-1 RA or GIP drugs. Those who received these medications had a 50% lower rate of alcohol intoxication compared to those who did not.

DISCOVER: Goodnight, sleep tight… thanks to this new app

MORE: This AI From Japan Can Detect If Cats Are In Pain

The findings extended to opioid addiction as well. The study looked at over 503,000 people with opioid use disorder, of which 8,103 had prescriptions for the same drugs. The researchers observed a 40% reduction in opioid overdoses among those using the medications.

“This is a significant breakthrough,” the authors wrote, adding that GLP-1 RA and GIP drugs “should be investigated as a novel pharmacotherapy treatment option” for addiction.

DISCOVER: AI Breakthrough Predicts Breast Cancer 5 Years Early—And We Finally Know How It Works

MORE: Teens are using social media to diagnose themselves with mental health issues

What Does This Mean for the Future of Addiction Treatment?

If these drugs prove effective in larger trials, they could revolutionise how addiction is treated. Unlike traditional medications, which often come with a stigma or intense side effects, GLP-1 RA and GIP drugs are already widely prescribed for other conditions. This could make them a more accessible and socially acceptable option for those seeking help.

DISCOVER: Tech Detox: how to set healthy boundaries with your devices

MORE: AI Imagined ‘Beautiful Women’ from 100 Countries Around the World

Public Figures Weigh In

The study comes amidst a broader conversation about the role of weight loss jabs in public health, as explained by The BBC. UK Health Secretary Wes Streeting recently warned against using these injections to achieve an “Instagram perfect body.” Meanwhile, Labour leader Sir Keir Starmer highlighted their potential to boost the economy by helping people “get back to work,” and Prime Minister Rishi Sunak noted they could ease the strain on the NHS.

As researchers delve deeper into the potential of these medications, the hope is that they might not only transform addiction treatment but also reshape societal attitudes toward health and recovery.